BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17414759)

  • 1. Magnetic resonance imaging of endometrial cancer and clear cell cancer.
    Manabe T; Hirose Y; Kiryuu T; Koudo H; Hoshi H
    J Comput Assist Tomogr; 2007; 31(2):229-35. PubMed ID: 17414759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review.
    Olawaiye AB; Boruta DM
    Gynecol Oncol; 2009 May; 113(2):277-83. PubMed ID: 19251307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma].
    Wang LX; Zhou CW; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):849-53. PubMed ID: 20137351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
    Silva EG; Young RH
    Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?
    Inada Y; Matsuki M; Nakai G; Tatsugami F; Tanikake M; Narabayashi I; Yamada T; Tsuji M
    Eur J Radiol; 2009 Apr; 70(1):122-7. PubMed ID: 18182265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial clear cell adenocarcinoma diagnosed by endometrial cytological examination: two cases report.
    Kinoshita Y; Takasu K; Adachi Y; Yuri T; Ikuta A; Shikata N
    Diagn Cytopathol; 2011 Mar; 39(3):200-3. PubMed ID: 21319323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MR imaging of uterine endometrial cancer.
    Tamai K; Koyama T; Saga T; Umeoka S; Mikami Y; Fujii S; Togashi K
    J Magn Reson Imaging; 2007 Sep; 26(3):682-7. PubMed ID: 17729360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
    Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
    Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear Cell Lesions of the Mullerian System: Not Always That "Clear"!
    Wawire J; Lawrence WD; Quddus MR
    Int J Surg Pathol; 2019 Dec; 27(8):884-886. PubMed ID: 30917732
    [No Abstract]   [Full Text] [Related]  

  • 15. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
    Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
    Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid progression of synchronous ovarian and endometrial cancers with massive omental carcinomatosis.
    Chia CC; Huang SC
    Taiwan J Obstet Gynecol; 2012 Sep; 51(3):452-4. PubMed ID: 23040937
    [No Abstract]   [Full Text] [Related]  

  • 17. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
    Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
    Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic endometrial endometrioid carcinoma with clear cell changes to the breast: a case report.
    Farghaly H
    Ann Diagn Pathol; 2013 Feb; 17(1):127-30. PubMed ID: 22048014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of stage III endometrial carcinoma].
    Li J; Kong WM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial endometrial spread of squamous cell cervical carcinoma: a diagnostic challenge at magnetic resonance imaging.
    Adler F; Rabban JT; Yeh BM; Qayyum A; Chen LM; Coakley FV
    J Comput Assist Tomogr; 2007; 31(2):247-50. PubMed ID: 17414762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.